101 Therapeutics Ltd. today announced the public release of its clinical and scientific evidence package for 101-PGC-005 (‘005), a macrophage-targeted dexamethasone prodrug designed to modulate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results